A novel auto-fluorescent porphyrin-lipid nanoparticle strategy for CTNNB1 gene silencing in hepatocellular carcinoma.
Saved in:
| Title: | A novel auto-fluorescent porphyrin-lipid nanoparticle strategy for CTNNB1 gene silencing in hepatocellular carcinoma. |
|---|---|
| Authors: | To JC; Ajmera Transplant Centre, University Health Network, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Apilan A; Ajmera Transplant Centre, University Health Network, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Pasini E; Ajmera Transplant Centre, University Health Network, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Mo Y; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Division of Gastroenterology and Hepatology, Toronto General Hospital, Health Network, Toronto, ON, Canada., Chen J; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Bakrania A; Ajmera Transplant Centre, University Health Network, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Bu J; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Pan A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Adeyi O; Department of Pathology and University of Minnesota Medical Center, University of Minnesota, Minneapolis, MN, United States.; Anatomic Pathology, The University of Alabama at Birmingham, Alabama, AL, United States., Vogel A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Division of Gastroenterology and Hepatology, Toronto General Hospital, Health Network, Toronto, ON, Canada.; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany., Zheng G; Ajmera Transplant Centre, University Health Network, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada., Bhat M; Ajmera Transplant Centre, University Health Network, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Division of Gastroenterology and Hepatology, Toronto General Hospital, Health Network, Toronto, ON, Canada.; Department of Medicine, University of Toronto., Toronto, ON, Canada.; Division of Gastroenterology & Hepatology, University of Toronto, Toronto, ON, Canada. |
| Source: | Frontiers in oncology [Front Oncol] 2026 May 08; Vol. 16, pp. 1779803. Date of Electronic Publication: 2026 May 08 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2026.1779803 |
